RECURSION PHARMACEUTICALS-A (RXRX) Institutional Ownership and Insiders Activity

RECURSION PHARMACEUTICALS-A (RXRX) is widely held by institutional investors, with 340 firms reporting positions valued at approximately $1.57B based on SEC Form 13F filings for the quarter ended September 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $220.87M in RXRX holdings in its latest filing.

Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.

Institutional Holders

340

Total Reported Value

$1.57B

Largest Holder

Blackrock, Inc.

Largest Position

$220.87M

Insider Transactions (90d)

12

Latest Filing Quarter

Q3 2026

New Institutional Positions

64

Funds Exiting Positions

58